Cadrenal Therapeutics, Inc. Business Finance Contracts & Agreements
29 Contracts & Agreements
- Assignment Agreements (1 contract)
- Investor Rights Agreements (1)
- Note Agreements (5)
- Purchase Agreements (4)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (10)
- Form of Registration Rights Agreement by and between Cadrenal Therapeutics, Inc. and the purchaser party thereto (Filed With SEC on July 14, 2023)
- Form of Securities Purchase Agreement, dated July 12, 2023, by and between Cadrenal Therapeutics, Inc. and the purchaser party thereto (Filed With SEC on July 14, 2023)
- Form of Placement Agent Warrant (Filed With SEC on July 14, 2023)
- Form of Warrant (Filed With SEC on July 14, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on July 14, 2023)
- Amendment to Asset Purchase Agreement, dated as of August 18, 2022, between the Company and HESP LLC (Filed With SEC on January 25, 2023)
- Representatives Warrant issued to Boustead Securities, LLC, dated January 19, 2023 (Filed With SEC on January 25, 2023)
- Underwriting Agreement, dated January 19, 2023, by and between Cadrenal Therapeutics, Inc. and Boustead Securities, LLC (Filed With SEC on January 25, 2023)
- Form of Underwriting Agreement by and between Cadrenal Therapeutics, Inc. and Boustead Securities,LLC, as representative of the underwriters (Filed With SEC on December 8, 2022)
- Form of Amendment to Convertible Promissory Note (Filed With SEC on December 6, 2022)
- Form of Placement Agent Warrant from November Private Placement (Filed With SEC on December 6, 2022)
- Form of Amended and Restated Placement Agent Warrant from Private Placement (Filed With SEC on December 6, 2022)
- Form of Amended and Restated November Warrant (Filed With SEC on December 6, 2022)
- Form of November Private Placement Promissory Note (Filed With SEC on December 6, 2022)
- Form of Underwriting Agreement by and between Cadrenal Therapeutics, Inc. and Boustead Securities,LLC, as representative of the underwriters (Filed With SEC on October 17, 2022)
- Form of Placement Agent Warrant (Filed With SEC on October 11, 2022)
- Form of Representatives Warrant Agreement (Filed With SEC on October 11, 2022)
- Specimen Common Stock Certificate (Filed With SEC on October 11, 2022)
- Form of Underwriting Agreement by and between Cadrenal Therapeutics, Inc. and Boustead Securities,LLC, as representative of the underwriters (Filed With SEC on October 11, 2022)
- Amendment to Asset Purchase Agreement, dated as of August 18, 2022, between Cadrenal Therapeutics, Inc. and HESP LLC (Filed With SEC on September 22, 2022)
- Form of Investor Rights and Lockup Agreement (Filed With SEC on September 22, 2022)
- Subscription Agreement with Quang Pham, dated January 25, 2022 (Filed With SEC on September 22, 2022)
- Patent Assignment Agreement dated as of April1, 2022, between Cadrenal Therapeutics, Inc. and HESP LLC (Filed With SEC on September 22, 2022)
- Asset Purchase Agreement dated as of April1, 2022, between Cadrenal Therapeutics, Inc. and HESP LLC (Filed With SEC on September 22, 2022)
- Restricted Stock Purchase Agreement with Matthew Szot (Filed With SEC on September 22, 2022)
- Form of Placement Agent Warrant (Filed With SEC on September 22, 2022)
- Form of Private Placement Convertible Note (Filed With SEC on September 22, 2022)
- Form of Convertible Note dated June13, 2022 (Filed With SEC on September 22, 2022)
- Convertible Promissory Note dated March1, 2022 issued to John Murphy (Filed With SEC on September 22, 2022)